John Wiley & Sons
The 10-second takeaway
For the quarter ended Jan. 31 (Q3), John Wiley & Sons beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded. Non-GAAP earnings per share expanded slightly. GAAP earnings per share contracted.
Gross margins grew, operating margins increased, net margins contracted.
John Wiley & Sons logged revenue of $472.4 million. The two analysts polled by S&P Capital IQ anticipated revenue of $455.9 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.93. The two earnings estimates compiled by S&P Capital IQ predicted $0.83 per share. Non-GAAP EPS of $0.93 for Q3 were 2.2% higher than the prior-year quarter's $0.91 per share. GAAP EPS of $0.95 for Q3 were 7.8% lower than the prior-year quarter's $1.03 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 70.0%, 150 basis points better than the prior-year quarter. Operating margin was 17.7%, 30 basis points better than the prior-year quarter. Net margin was 12.1%, 180 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $465.0 million. On the bottom line, the average EPS estimate is $0.85.
Next year's average estimate for revenue is $1.76 billion. The average EPS estimate is $2.98.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on John Wiley & Sons is outperform, with an average price target of $47.67.
Can your portfolio provide you with enough income to last through retirement? You'll need more than John Wiley & Sons. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add John Wiley & Sons to My Watchlist.